ABQ Health Partners adopts Aternity FPI Platform
ABQ Health Partners will monitor and analyze the performance of its Electronic Health Record (EHR) solution with the help of Aternity. Aternity will provide FPI Platform, transforming desktop
Evogene and ELEO have entered a scientific collaboration aimed at discovering and developing new oral small-molecule inhibitors targeting the Proprotein convertase subtilisin/kexin type 9 (PCSK9) pathway for hyperlipidemia and cardiovascular diseases.